Full text
| |
| Author(s): |
Patrícia Rezende
Total Authors: 1
|
| Document type: | Doctoral Thesis |
| Press: | Campinas, SP. |
| Institution: | Universidade Estadual de Campinas (UNICAMP). Instituto de Química |
| Defense date: | 2007-06-09 |
| Examining board members: |
Fernando Antonio Santos Coelho;
Silvio do Desterro Cunha;
Sergio Pinheiro;
Ronaldo Aloise Pilli;
Raquel Marques Braga
|
| Advisor: | Fernando Antonio Santos Coelho |
| Abstract | |
This work has been as main purpose the synthesis and the biological evaluation of some 2-oxazolidinones. These compounds have been used as substrates for the preparation of different compounds and used as chiral auxiliary in asymmetric organic synthesis. Besides the synthetic relevance of this class of compounds, they also exhibit important biological effects, as neuroleptic, psychotropic, anti-allergenic and antibacterial. In the last years, an special attention has been paid to these compounds due to their antibacterial activity, since they show a remarkable activity against Gram-positive drugs multi-resistant strains, through a new action mechanism. In this work several 4- and 4,5-substituted oxazolidinones were synthesized from Morita-Baylis-Hillman prepared from aliphatic and aromatic commercial aldehydes, using two synthetic approaches. The first approach was based on employing a Curtius rearrangement, and the second was based on the utilization of an ozonolysis reaction of the MBH adducts. Both synthetic approaches have permitted preparing several oxazolidinones. An advanced intermediate for the total synthesis of isocytoxazone, a structural isomer of cytoxazone, was also prepared. Cytoxazone, a natural oxazolidinone, exhibits cytocine modulator activity for Th2 cells. Through an adaptation of the strategy based on Curtius rearrangement, we have also synthesized a, b-unsaturated ketones from MBH adducts. Finally, a study was started aiming at synthesizing chiral oxazolidinones, using chiral base b-isocupreidine prepared by us. Synthetic oxazolidinones prepared in this work are under biological screening for evaluating theirs antibacterial profiles (AU) | |